BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29611696)

  • 1. Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.
    Côrte-Real L; Teixeira RG; Gírio P; Comsa E; Moreno A; Nasr R; Baubichon-Cortay H; Avecilla F; Marques F; Robalo MP; Mendes P; Ramalho JPP; Garcia MH; Falson P; Valente A
    Inorg Chem; 2018 Apr; 57(8):4629-4639. PubMed ID: 29611696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.
    Côrte-Real L; Robalo MP; Marques F; Nogueira G; Avecilla F; Silva TJ; Santos FC; Tomaz AI; Garcia MH; Valente A
    J Inorg Biochem; 2015 Sep; 150():148-59. PubMed ID: 26150132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand.
    Côrte-Real L; Karas B; Gírio P; Moreno A; Avecilla F; Marques F; Buckley BT; Cooper KR; Doherty C; Falson P; Garcia MH; Valente A
    Eur J Med Chem; 2019 Feb; 163():853-863. PubMed ID: 30579125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
    Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
    Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
    J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cobalt(II) complexes with dipyridylamine and salicylaldehydes on cultured tumor and non-tumor cells: synthesis, crystal structure investigations and biological activity.
    Lalia-Kantouri M; Gdaniec M; Choli-Papadopoulou T; Badounas A; Papadopoulos CD; Czapik A; Geromichalos GD; Sahpazidou D; Tsitouroudi F
    J Inorg Biochem; 2012 Dec; 117():25-34. PubMed ID: 23078772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinuclear Ru
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel family of [RuCp(N,N)(P)]
    Teixeira RG; Mészáros JP; Matos B; Côrte-Real L; Xavier CPR; Fontrodona X; Garcia MH; Romero I; Spengler G; Vasconcelos MH; Tomaz AI; Enyedy ÉA; Valente A
    Eur J Med Chem; 2023 Dec; 262():115922. PubMed ID: 37944388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structural characterization of ternary Cu (II) complexes of glycine with 2,2'-bipyridine and 2,2'-dipyridylamine. The DNA-binding studies and biological activity.
    Mohamed MS; Shoukry AA; Ali AG
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 86():562-70. PubMed ID: 22153742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.
    Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
    Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties.
    Marcon G; Carotti S; Coronnello M; Messori L; Mini E; Orioli P; Mazzei T; Cinellu MA; Minghetti G
    J Med Chem; 2002 Apr; 45(8):1672-7. PubMed ID: 11931621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of ruthenium complexes bearing the 1,2,4-triazole group as potential membrane-targeting antibacterial agents towards
    Wang P; Huang HY; Dou LX; Deng W; Wang JT; Liao XW; Yu RJ; Duan XM; Xiong YS
    Dalton Trans; 2023 Jun; 52(25):8737-8746. PubMed ID: 37313713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells.
    Teixeira RG; Brás AR; Côrte-Real L; Tatikonda R; Sanches A; Robalo MP; Avecilla F; Moreira T; Garcia MH; Haukka M; Preto A; Valente A
    Eur J Med Chem; 2018 Jan; 143():503-514. PubMed ID: 29202411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.
    Kohler L; Nease L; Vo P; Garofolo J; Heidary DK; Thummel RP; Glazer EC
    Inorg Chem; 2017 Oct; 56(20):12214-12223. PubMed ID: 28949518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile ruthenium complexes based on 2,2'-bipyridine modified peptoids.
    Baskin M; Panz L; Maayan G
    Chem Commun (Camb); 2016 Aug; 52(68):10350-3. PubMed ID: 27349289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological properties of tetranuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand.
    Sun B; Sundaraneedi MK; Southam HM; Poole RK; Musgrave IF; Keene FR; Collins JG
    Dalton Trans; 2019 Oct; 48(38):14505-14515. PubMed ID: 31531475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luminescent ruthenium complexes for theranostic applications.
    Cardoso CR; Lima MV; Cheleski J; Peterson EJ; Venâncio T; Farrell NP; Carlos RM
    J Med Chem; 2014 Jun; 57(11):4906-15. PubMed ID: 24831959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of an intermolecular RNA triplex by two novel binders Lys- and Arg-rich Ru(II) polypyridyl metallopeptides.
    Zhu J; Wang F; Liu X; Tan L
    J Inorg Biochem; 2020 Sep; 210():111171. PubMed ID: 32652263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.